Table 2. Malaria Status of Pregnant Women During Pregnancy Versus Demographic, obstetric, clinical and laboratory history at follow-up.
| Variable | Had malaria detected during pregnancy, 94(54%) | Had no evidence of malaria infection during pregnancy, 81(46%) | P value* |
|---|---|---|---|
| Mean Gestation Age, weeks (±SD) at enrolment | 21.3 ± 6.4 | 21.4±6.3 | 0.93 |
| Parity | |||
| Primiparous | 41(58.6%) | 29(41.4%) | 0.35 |
| Multiparous | 53(50.4%) | 52(49.5%) | |
| Hemoglobin (Hb) level at enrolment** | |||
| Moderate Anemia (Hb <11g/dl) | 49(56.3%) | 38(43.7%) | 0.54 |
| No Anemia (Hb ≥11g/dl) | 45(51.1%) | 43(48.9%) | |
| Age at enrolment | |||
| <20 years | 46(57.8%) | 36(43.9%) | 0.66 |
| 20 – 30 years | 38(50.0%) | 38(50.0%) | |
| >30 years | 10(58.8%) | 7(41.2%) | |
| Bed net use at enrolment | |||
| Yes | 71(53%) | 64(47%) | 0.71 |
| No | 23(57%) | 17(43%) | |
| EBV DNA Prevalence at enrolment | |||
| EBV DNA Positive | 50(64%) | 28(36%) | 0.01 |
| EBV DNA Negative | 44(45%) | 53(55%) | |
*
All estimated using Fisher's exact test except gestation age, which was estimated by unpaired t-test. All tests of statistical significance are two sided.
**
Cut-off as defined by the World Health Organization (WHO) for pregnant women(35)